Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,224.60
Bid: 1,224.40
Ask: 1,224.80
Change: -18.40 (-1.48%)
Spread: 0.40 (0.03%)
Open: 1,248.00
High: 1,248.20
Low: 1,224.00
Yest. Close: 1,243.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

LIVE MARKETS-Opening snapshot: Europe wavers before the ECB

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) i...

10 Sep 20 08:33

LIVE MARKETS-On our radar: euro, IAG cap rise and dealmaking

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) i...

10 Sep 20 07:50

GlaxoSmithKline Gains FDA Approval For Trelegy Use As Asthma Treatment

GlaxoSmithKline Gains FDA Approval For Trelegy Use As Asthma Treatment

10 Sep 20 06:21

Jefferies says short-term correction in AstraZeneca may prove misplaced

(Sharecast News) - Analysts at Jefferies reiterated their 'hold' recommendation for shares of AstraZeneca following the pharma giant's decision to press the pause button on its phase three clinical trial for the Covid-19 vaccine under development alongside the University of Oxford.

9 Sep 20 13:25

UPDATE 1-AstraZeneca pauses coronavirus vaccine trial, shares slip on rollout doubts

(Adds reaction, links, updates share price move)LONDON, Sept 9 (Reuters) - AstraZeneca has suspended global trials of its experimental coronavirus vaccine after an unexplained illness in a participant, knocking the British drugmaker's shares on We...

9 Sep 20 13:02

UPDATE 2-AstraZeneca pauses coronavirus vaccine trial, shares slip on rollout doubts

* Trials halted due to health condition of a participant* Independent panel to review any link to vaccine prototype* AstraZeneca has supply deals for 3 bln doses (Adds details in British trial, expert comment, FT report)By Ludwig BurgerLONDON, Sept ...

9 Sep 20 13:02

BioNTech and Pfizer announce positive result in pre-clinical trial for Covid-19 vaccine

(Sharecast News) - One of the Covid-19 vaccine candidates being developed by German outfit BioNTech and Pfizer succeeded in pre-clinical challenge trials.

9 Sep 20 12:52

UPDATE 3-FTSE 100 helped by weak pound; New COVID-19 restrictions hit consumer stocks

* AstraZeneca pauses trials of coronavirus vaccine* England bans gatherings of more than six people* No-deal Brexit fears send pound to six-week low (Adds details, updates to market close)By Shashank Nayar and Ambar WarrickSept 9 (Reuters) - London'...

9 Sep 20 09:59

AstraZeneca pauses coronavirus vaccine trial, rollout doubts dent shares

LONDON, Sept 9 (Reuters) - AstraZeneca has paused global trials of its experimental coronavirus vaccine after an unexplained illness in a participant, denting the British drugmaker's shares on Wednesday as the move was seen as dimming prospects f...

9 Sep 20 09:25

AstraZeneca pauses Covid-19 vaccine trial to review safety data

(Sharecast News) - AstraZeneca paused the phase three clinical trial of the Covid-19 vaccine candidate that it was developing in conjunction with the University of Oxford, in response to a possible unexplained illness in one of the participants.

9 Sep 20 01:13

UPDATE 1-AstraZeneca puts COVID-19 vaccine trial on hold over safety concern -Stat News

(Adds background, detail on trial subject)Sept 8 (Reuters) - AstraZeneca Plc has put a hold on the late-stage trial of its highly-anticipated COVID-19 vaccine candidate after a suspected serious adverse reaction in a study participant, health news...

8 Sep 20 23:30

UPDATE 2-AstraZeneca puts COVID-19 vaccine trial on hold over safety concern -Stat News

(Adds quote attributed by Stat to AstraZeneca, details)Sept 8 (Reuters) - AstraZeneca Plc has paused a late-stage trial of one of the leading COVID-19 vaccine candidates after a suspected serious adverse reaction in a study participant, health new...

8 Sep 20 23:30

UPDATE 3-AstraZeneca puts leading COVID-19 vaccine trial on hold over safety concern

(Adds AstraZeneca comment, Moderna comment, byline)By Deena BeasleySept 8 (Reuters) - AstraZeneca Plc on Tuesday said it has paused a late-stage trial of one of the leading COVID-19 vaccine candidates after an unexplained illness in a study partic...

8 Sep 20 23:30

UPDATE 1-U.S., European COVID vaccine developers pledge to uphold testing rigour

* Companies pledge to uphold integrity of scientific process* Debate about speed of development has become heated* Mass testing with control groups are needed - statement (Adds industry comment, background)By Ludwig Burger, Patricia Weiss and Caroli...

8 Sep 20 13:44

UPDATE 2-U.S., European COVID-19 vaccine developers pledge to uphold testing rigour

* Companies pledge to uphold integrity of scientific process* Debate about speed of development has become heated* Mass testing with control groups are needed - statement (Adds Inovio CEO comment)By Ludwig Burger, Patricia Weiss and Caroline CopleyF...

8 Sep 20 13:44

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.